These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37861912)

  • 41. Circulatory Rejuvenated EPCs Derived from PAOD Patients Treated by CD34
    Chen YC; Sheu JJ; Chiang JY; Shao PL; Wu SC; Sung PH; Li YC; Chen YL; Huang TH; Chen KH; Yip HK
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-cell transcriptomic profiling and characterization of endothelial progenitor cells: new approach for finding novel markers.
    Abdelgawad ME; Desterke C; Uzan G; Naserian S
    Stem Cell Res Ther; 2021 Feb; 12(1):145. PubMed ID: 33627177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts.
    Orlova VV; Drabsch Y; Freund C; Petrus-Reurer S; van den Hil FE; Muenthaisong S; Dijke PT; Mummery CL
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):177-86. PubMed ID: 24158517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial Cell Inflammation and Antioxidant Capacity are Associated With 6-Minute Walk Performance in Patients With Symptomatic Peripheral Artery Disease.
    Gardner AW; Montgomery PS; Zhao YD; Ungvari Z; Csiszar A; Sonntag WE
    Angiology; 2018 May; 69(5):416-423. PubMed ID: 28835113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced mRNA and Protein Expression Levels of Tet Methylcytosine Dioxygenase 3 in Endothelial Progenitor Cells of Patients of Type 2 Diabetes With Peripheral Artery Disease.
    Zhao S; Jia T; Tang Y; Zhang X; Mao H; Tian X; Li R; Ma L; Chen G
    Front Immunol; 2018; 9():2859. PubMed ID: 30574144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.
    Gu M; Mordwinkin NM; Kooreman NG; Lee J; Wu H; Hu S; Churko JM; Diecke S; Burridge PW; He C; Barron FE; Ong SG; Gold JD; Wu JC
    Eur Heart J; 2015 Apr; 36(13):806-16. PubMed ID: 25368203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke.
    Regueiro A; Cuadrado-Godia E; Bueno-Betí C; Diaz-Ricart M; Oliveras A; Novella S; Gené GG; Jung C; Subirana I; Ortiz-Pérez JT; Roqué M; Freixa X; Núñez J; Escolar G; Marrugat J; Hermenegildo C; Valverde MA; Roquer J; Sanchis J; Heras M
    J Mol Cell Cardiol; 2015 Mar; 80():146-55. PubMed ID: 25619946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.
    Raval Z; Losordo DW
    Circ Res; 2013 Apr; 112(9):1288-302. PubMed ID: 23620237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human endothelial colony-forming cells provide trophic support for pluripotent stem cell-derived cardiomyocytes via distinctively high expression of neuregulin-1.
    Hong X; Oh N; Wang K; Neumeyer J; Lee CN; Lin RZ; Piekarski B; Emani S; Greene AK; Friehs I; Del Nido PJ; Melero-Martin JM
    Angiogenesis; 2021 May; 24(2):327-344. PubMed ID: 33454888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical application of vascular regenerative therapy for peripheral artery disease.
    Suzuki H; Iso Y
    Biomed Res Int; 2013; 2013():179730. PubMed ID: 24350247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired vascular function and repair in patients with premature coronary artery disease.
    Brittan M; Hunter A; Boulberdaa M; Fujisawa T; Skinner EM; Shah AS; Baker AH; Mills NL
    Eur J Prev Cardiol; 2015 Dec; 22(12):1557-66. PubMed ID: 26276790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial progenitor cells in patients with severe peripheral arterial disease.
    Delva P; De Marchi S; Prior M; Degan M; Lechi A; Trettene M; Arosio E
    Endothelium; 2008; 15(5-6):246-53. PubMed ID: 19065316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
    Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34
    Qin M; Guan X; Wang H; Zhang Y; Shen B; Zhang Q; Dai W; Ma Y; Jiang Y
    Stem Cell Res Ther; 2017 Feb; 8(1):25. PubMed ID: 28173870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease.
    Shaffer RG; Greene S; Arshi A; Supple G; Bantly A; Moore JS; Parmacek MS; Mohler ER
    Vasc Med; 2006 Nov; 11(4):219-26. PubMed ID: 17390544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells.
    Chang WY; Lavoie JR; Kwon SY; Chen Z; Manias JL; Behbahani J; Ling V; Kandel RA; Stewart DJ; Stanford WL
    Stem Cell Res; 2013 Mar; 10(2):195-202. PubMed ID: 23291290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.
    Samuel R; Daheron L; Liao S; Vardam T; Kamoun WS; Batista A; Buecker C; Schäfer R; Han X; Au P; Scadden DT; Duda DG; Fukumura D; Jain RK
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12774-9. PubMed ID: 23861493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential.
    Pyšná A; Bém R; Němcová A; Fejfarová V; Jirkovská A; Hazdrová J; Jude EB; Dubský M
    Stem Cell Rev Rep; 2019 Apr; 15(2):157-165. PubMed ID: 30413930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells.
    Chao TH; Chen IC; Li YH; Lee PT; Tseng SY
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.